Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivityQuan Zheng, Christopher Heeschen, Jiajia Tang et al.|Journal of Experimental & Clinical Cancer Research|2023Cited by 17